Vaccine Market Overview in the Czech Republic
In value terms, vaccine production expanded significantly to $ in 2019 estimated in export prices. The total output value increased at an average annual rate of +% from 2007 to 2019; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2009 when the production volume increased by % year-to-year. As a result, production reached the peak level of $. From 2010 to 2019, production growth remained at a lower figure.
The revenue of the vaccine market in the Czech Republic rose slightly to $ in 2019, picking up by % against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2011 with an increase of % y-o-y. Over the period under review, the market hit record highs at $ in 2013; however, from 2014 to 2019, consumption remained at a lower figure.